Summary
Xanthoma disseminatum (XD) is a rare benign histiocytic disorder with extensive cutaneous and mucous membrane xanthomas in normolipemic patients. We describe the 9-year course of a 25-year-old white man who presented with multiple brownish-reddish papulous skin tumors that developed over 3 years and remained relatively constant, with spontaneous regression and progression of individual lesions since. In addition, there was asymptomatic xanthomatous infiltration of the epipharnyx and symptomatic infiltration of the synovial membrane of the left knee joint leading to restriction of movement. Histologically, the corium was infiltrated by large lipid-storing macrophages, polynucleated histiocytic giant cells of the Touton and the foreign body type. Immunhistochemically, the lipid-storing cells could be classified as macrophage/monocyte derived cells distinctly different from Langerhans' cells without proliferative activity. The clinical picture and course as well as laboratory findings indicating normolipidemia made it possible to differentiate XD from other normolipemic xanthomatosis, especially juvenile xanthogranuloma, eruptive histiocytoma, and histiocytosis X. The etiology of XD is still unknown. It is possible to differentiate xanthoma disseminatum from malignant histiocytosis X by the clinical picture and immunhistochemical studies. Thus it is no longer justified to administer cytostatic treatment for this disorder.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Abbreviations
- XD:
-
xanthoma disseminatum
References
Abrams JJ, Grundig SM, Kane JP, Chang CM (1979) Normocholesterolemic dysbetalipoproteinemia with xanthomatosis. Metabolism 28:113–124
Altman J, Winkelmann RK (1962) Xanthoma disseminatum. Arch Dermatol 86:582–596
Arnold ML, Wirth H, Anton-Lamprecht I, Petzoldt D (1982) Generalisierte eruptive Histiozytome. Hautarzt 33:428–437
Battaglini J, Olsen T (1984) Disseminated xanthosiderohistiocytosis, a variant of xanthoma disseminatum, in a patient with a plasma cell dyscrasia. J Am Acad Dermatol 11:750–755
Björkheim I, Skrede S (1989) Familial diseases with storage of sterols other than cholesterol: cerebrotendinous xanthomatosis and phytosterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1283–1302
Blobstein SH, Caldwell D, Carter DM (1985) Bone lesions in xanthoma disseminatum. Arch Dermatol 121:1313–1317
Braun-Falco O (1973) Origin, structure, and function of the xanthoma cell. Nutr Metabol 15:68–88
Braun-Falco O, Korting HC, Zienicke H, Klövekorn W (1988) Eruptive Histiozytome und Xantoma disseminatum als Manifestationsformen derselben Erkrankung? Hautarzt 39:652–657
Brunzell JD (1989) Familial lipoprotein lipase deficiency and other causes of the chylomicronemia syndrome. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1165–1180
Coldiron BM, Cruz PD, Freeman RG, Sontheimer RD (1988) Benign non-X histiocytosis: a unique case bridging several of the non-X histiocytic syndromes. J Am Acad Dermatol 18:1282–1289
Feingold KR, Castro GR, Ishikawa Y, Fielding PE, Fielding CJ (1989) Cutaneous xanthoma in association with paraproteinemia in the absence of hyperlipidemia. J Clin Invest 83:797–802
Ferrando J, Bombi JA (1979) Ultrastructural aspects of normolipidemic xanthomatosis. Arch Dermatol Res 266:143–159
Flach DB, Winkelmann RK (1986) Juvenile xanthogranuloma with central nervous lesions. J Am Acad Dermatol 14:405–411
Fleischmajer R, Tint GS, Bennett HD (1981) Normolipemic tendon and tuberous xanthomas. J Am Acad Dermatol 5:290–296
Frank SB, Weidman AI (1952) Xanthoma disseminatum. An unusual form with extension of xanthomatous changes into muscle. Archives of Dermatology and Syphylus 65:88–94
Giller RH, Folberg R, Keech RV, Piette WW, Sato Y (1988) Xanthoma disseminatum. An unusual histiocytosis syndrome. Am J Pediatr Hematol Oncol 10:252–257
Goldstein JL, Brown MS (1989) Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw Hill, New York, pp 1215–1250
von Gräfe (1867) Verhandlungen ärztlicher Gesellschaften: ein Fall von eigentümlichen Tumoren auf Hornhäuten. Klin Wochenschr 4:323
Greenberger JS, Corcker AC, Vawter G, Jaffe N, Cassady JR (1981) Results of treatment of 127 patients with systemic histiocytosis (Letterer-Siwe syndrome, Schuller-Christian syndrome and multifocal eosinophilic granuloma). Medicine 60:311–338
Harrlan WR, Still WJS (1968) Hereditary tendinous and tuberous xanthomatosis without hyperlipidemia. N Engl J Med 278:416–422
Kalz F, Hofmann MM, LaFrance A (1970) Xanthoma disseminatum: clinical and laboratory observations over a ten year period. Dermatologica 140:129–141
Kumakiri M, Sudoh M, Miura Y (1981) Xanthoma disseminatum. Report of a case, with histological and ultrastructural studies of skin lesions. J Am Acad Dermatol 4:291–299
Knobler RM, Neumann RA, Gebhart W, Radaskiewicz T, Ferenci P, Widhalm K (1990) Xanthoma disseminatum with progressive involvement of the central nervous and hepatobiliary system. J Am Acad Dermatol 23:341–346
Kwiterovich PO, Bachorik PS, Smith HH, McKusick VA, Connor WE, Teng B, Sniderman AD (1981) Hyperapobetalipoproteinaemia in two families with xanthomas and phytosterolaemia. Lancet 1:466–469
Mahley RW, Rall SC (1989) Type III hyperlipoproteinemia (dysbetalipoproteinemia): the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 1195–1214
Moloney JR (1979) Xanthoma disseminatum: its otolaryngological manifestations. J Laryngol Otol 93:201–210
Montgomery H (1939) Cutaneous Xanthomatosis. Ann Intern Med 13:671–676
Montgomery H, Osterberg AE (1938) Xanthomatosis: correlation of clinical, histopathologic and chemical studies of cutaneous xanthoma. Archives of Dermatology and Syphylus 37:373–402
Parker F (1986) Normocholesterolemic xanthomatosis. Arch Dermatol 122:1253–1257
Polano MK (1973) Xanthoma types in relation to the type of hyperlipoproteinemia. Nutr Metabol 15:107–118
Puig ML, Webb SM, DelPozo C, deJuan M, Serrano S, Vilardell E (1987) Endocrine aspects of pituitary stalk enlargement. Clin Endocrinol (Oxf) 27:25–32
Ringel E, Moschella S (1985) Primary histiocytic dermatoses. Arch Dermatol 121:1531–1541
Sanchez RL, Raimer SS, Peltier F, Swedo J (1985) Papular xanthoma. Arch Dermatol 121:626–631
Szekeres E, Tiba A, Korom I (1988) Xanthoma disseminatum: a rare condition with non-X, non-lipid cutaneous histiocytopathy. J Dermatol Surg Oncol 14:1021–1024
Thannhauser S (1958) Lipi-doses: diseases of the intracellular lipid metabolism. Grune & Stratton, New York, pp 354–380
Wilson DE, Flowers CM, Hershgold EJ, Eaton RP (1975) Multiple myeloma, cryoglobulinemia and xanthomatosis. Am J Med 59:721–729
Winkelmann RK (1981) Cutaneous syndromes of non-X-histiocytosis. Arch Dermatol 117:667–672
Wolff HH, Vigl E, Braun-Falco O (1975) Juveniles Xanthogranulom und Organmanifestationen. Hautarzt 26:268–272
Writing group of the histiocyte Society (1987) Histiocytosis syndromes in children. Lancet 1:208–209
Zöllner N (1964) Die Speicherkrankheiten des retikuloendothelialen Systems. In: Heilmeyer L, Hittmair A (eds) Handbuch der gesamten Hämatologie, vol 5: Spezielle Hamatologie. Urban & Schwarzenberg, Munich, pp 184–209
Author information
Authors and Affiliations
Additional information
Dedicated to Prof Dr. N. Zöllner on the occasion of his 70th birthday
Rights and permissions
About this article
Cite this article
Weiss, N., Keller, C. Xanthoma disseminatum: a rare normolipemic xanthomatosis. Clin Investig 71, 233–238 (1993). https://doi.org/10.1007/BF00180107
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00180107